ATX 2.33% 8.8¢ amplia therapeutics limited

Good question It does say in the announcement … The proposed...

  1. 2,132 Posts.
    lightbulb Created with Sketch. 668
    Good question

    It does say in the announcement …

    The proposed trial will explore the safety, tolerability and efficacy of a combination of narmafotinib with the chemotherapy regime FOLFIRINOX.

    So Presumably not … as the wording says, explore safety tolerability and efficacy


    As we know efficacy was not officially tested in the Australian phase 1b trail …

    .
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
8.8¢
Change
0.002(2.33%)
Mkt cap ! $24.13M
Open High Low Value Volume
8.6¢ 9.2¢ 8.5¢ $53.15K 599.3K

Buyers (Bids)

No. Vol. Price($)
4 44983 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 7898 1
View Market Depth
Last trade - 14.49pm 31/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.